- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.52 Å
- Oligo State
- hetero-3-2-mer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 53 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Non-functional Binders)(Post Translational Modification)
NAG.10: 4 residues within 4Å:- Chain A: Y.25, N.58, S.254, W.255
Ligand excluded by PLIPNAG.11: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.12: 4 residues within 4Å:- Chain A: S.152, L.154, V.156, Y.157
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain A: Y.141, N.146, K.147
Ligand excluded by PLIPNAG.14: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain A: K.110
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain A: N.279, T.281
- Chain D: K.555
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: N.328, Q.577
Ligand excluded by PLIPNAG.18: 14 residues within 4Å:- Chain A: S.405, Q.406, A.408, P.409, G.410, Q.411, T.412, G.413, N.414, I.415, A.416, D.417, K.421, L.422
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain A: N.600
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain A: N.613
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain A: N.654
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: N.706
- Chain B: Y.793
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain A: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.1131
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain B: Y.25, N.58, S.254, W.255
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain B: N.71
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: S.152, L.154, Y.157
Ligand excluded by PLIPNAG.28: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.29: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.30: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain A: K.555
- Chain B: N.279
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.328, I.329
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: K.437, L.438
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.600
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: N.613, T.615
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: Y.652, N.654
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: N.706
- Chain D: Y.793
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: N.1095, T.1097, H.1098
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain B: N.1131
Ligand excluded by PLIPNAG.40: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.41: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain C: S.402, D.525, N.528
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.72
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: N.304, M.305
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain C: N.35, T.37, E.39, N.40
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain D: Y.25, N.58
Ligand excluded by PLIPNAG.49: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain D: L.154, Y.157
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain D: Y.141, R.149
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain B: K.555
- Chain D: N.279
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain D: N.328, I.329, N.331, L.332
Ligand excluded by PLIPNAG.54: 8 residues within 4Å:- Chain D: Q.406, A.408, Q.411, T.412, G.413, A.416, D.417, K.421
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain D: N.600
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain D: N.613
Ligand excluded by PLIPNAG.57: 2 residues within 4Å:- Chain D: Y.652, N.654
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain A: Y.793
- Chain D: N.706
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain D: N.1095, T.1097, H.1098
Ligand excluded by PLIPNAG.60: 1 residues within 4Å:- Chain D: N.1131
Ligand excluded by PLIPNAG.63: 3 residues within 4Å:- Chain E: S.402, S.527, N.528
Ligand excluded by PLIPNAG.64: 2 residues within 4Å:- Chain E: N.72, T.74
Ligand excluded by PLIPNAG.65: 1 residues within 4Å:- Chain E: N.304
Ligand excluded by PLIPNAG.66: 4 residues within 4Å:- Chain E: N.35, T.37, E.39, Q.322
Ligand excluded by PLIP- 2 x ZN: ZINC ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cao, Y. et al., Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe (2022)
- Release Date
- 2022-10-19
- Peptides
- Spike glycoprotein: ABD
Angiotensin-converting enzyme 2: CE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CD
FC
DE
G
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.52 Å
- Oligo State
- hetero-3-2-mer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 53 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Non-functional Binders)(Post Translational Modification)
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cao, Y. et al., Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe (2022)
- Release Date
- 2022-10-19
- Peptides
- Spike glycoprotein: ABD
Angiotensin-converting enzyme 2: CE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CD
FC
DE
G